Skip to content

Neogen NEOG EV / sales

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Idexx Laboratories logo
Idexx LaboratoriesIDXX
10.1×+1.3×
Zoetis logo
ZoetisZTS
6.1×-2.4×
Revvity logo
RevvityRVTY
4.4×-0.9×
Agilent Technologies logo
Agilent TechnologiesA
4.8×-0.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
3.1×+0.1×

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+86.4%
Enterprise value$2.63B+41.6%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on the most recent quarter.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's EV / sales?
Neogen (NEOG) reported EV / sales of 3.5× in Q4 2025.
How has Neogen's EV / sales changed year-over-year?
Neogen's EV / sales increased by 8.7% year-over-year, from 3.3× to 3.5×.
What is the long-term trend for Neogen's EV / sales?
Over 4 years (2021 to 2025), Neogen's EV / sales has grown at a -31.0% compound annual growth rate (CAGR), from 10.5× to 2.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.